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INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ABSTRACT 
 
 
Purpose of The Study:  
                                    To study the visual outcome in posterior capsular 
opacification treated with Nd : YAG Laser Posterior capsulotomy.  
                                    To Analyse the  complications following Nd : YAG 
Laser  capsulotomy like increased IOP, IOL markings, Retinal detachment, 
etc., 
 
Materials and Methods: 
                                       We selected patients with visual deterioration due to 
posterior capsular opacification in our department of totally hundred patients. 
Before the procedure, visual acquity, IOP and posterior segment were 
examined for all the patients. Nd:YAG Laser capsulotomy performed and 
rechecked the parameters immediately after the procedure and after one hour, 
one day, one week, one month and three months. 
 
 Results 
                Visual acquity improved in 96% of our patients , 4% showed no 
improvement, which was related to previous retinal problems and thick 
posterior capsule 
                 Transient elevation of IOP above 21mm Hg was noted in 2 
patients within 24 hours. Post laser Uveitis was observed in 1 patients which 
was controlled with steroid eye drops within one week. 
 
Conclusion 
                   The Nd : YAG Laser is a non invasive surgical tool that provides 
excellent posterior capsulotomies with minimal complications. From the 
above study, it’s clear that Nd:YAG Laser posterior capsulotomy is safe and 
effective procedure for creating capsular opening compared to invasive 
surgical procedures. The post operative results are very good and the 
complication rate is very low.  
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INTRODUCTION 
 
Technological advances in the medical field changed  so many things 
in the management of medical diseases . LASER is one of the major 
break through in treating medical problems. For the past four decades, 
LASER has been applied in the management and still extensive 
investigations are underway. As a less invasive therapeutic modality , 
the use of laser is Expanding in numerous conditions . 
 
The field of ophthalmology was one of the first to put laser to broad 
use, with modern ophthalmic practice routinely using laser in the 
treatment of certain ophthalmic diseases. 
Femto second YAG Lasers are the latest, but certainly not the last, 
lasers to be introduced into the eyes as a blade. The most common 
application has been in the use of posterior capsulotomies in aphakic or 
pseudophakic patients
1,2
. Increased use of extracapsular cataract 
extraction along with an increasing tendency to leave the posterior 
capsules initially intact at the end of surgery has resulted in an 
increased  number of opaque posterior capsules at a later date
1,16,17
.  
2 
 
Although these numbers will vary depending upon the surgeon and 
technique utilized, it would probably be safe to estimate that these are 
at least 30% over a long period of time
2
. For opening the posterior 
capsular opacities , the non invasive characteristics of  the Nd :YAG  
LASER  provides an excellent treatment modality  
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AIM OF THE STUDY 
 To study the efficacy of Nd:YAG laser capsulotomy in posterior 
capsular opacification by analyzing the visual outcome. 
 To study the intraocular pressure changes and other complications 
following   Nd:YAG laser capsulotomy. 
 
 
 
 
 
 
 
 
 
 
4 
HISTORICAL CONSIDERATIONS 
The recognition that the radiant energy of the sun could damage the 
human eye was the first step in the development of ocular 
phototherapy. 
 Bonetus, an ophthalmologist in Geneva in the 17th century, first 
described the occurance of scotoma after sungazing. 
 Czemy (1867)  & Deutschman (1882) focused sunlight on the 
retina of rabbits  by means of concave mirror and convex lenses 
and produced hyperpigmented scars. 
 Modern history of photocoagulation began with the work of Gerd 
Meyer Schwickerath, a young ophthalmologist at the University 
of  Hamburg, who demonstrated that focused radiant energy 
could be used to create choriorentinal lesions of clinical value. 
He developed a photocoagulator, using the Sun as its light source. 
It consisted of a Galilean telescope with a mirror that had a  
Central aperture and was suspended on an universal joint in front of the 
ocular. He then employed as improved carbon arc and finally xenon-arc 
lamp. 
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Development of Laser 
 Theodore Maiman built the first laser, which employed ruby 
crystal as medium, in July 1960. 
 In 1961, Zaret employed a ruby laser for iris, retinal 
photocoagulation in rabbits. 
 The ruby laser was quickly supplemented with introduction of 
Argon laser photocoagulator. Earliest work in the development of 
Argon laser was done by L‟Esperance and followed by studies of 
Zweng, Little, Patz and others. 
Laser Effects on Tissues 
 Photo disruption 
 Photo ablation 
 Photo coagulation 
Development of Photodisruption 
 It can be defined as the use of high peak power ionizing laser 
pulse to disrupt tissue. Light energy is concentrated in time and 
space to create optical breakdown and ionization of target 
medium with formation of plasma, which is seen as a park. 
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 Krasnov–First to demonstrate that high peak power pulses could 
be used to produce clinically desirable disruption of ocular 
structures. He used „Q-switched‟ ruby laser to treat trabecular 
meshwork of open angle glaucoma and called it as laser 
goniopuncture. He also successfully ruptured the anterior capsule 
in  rabbit eyes. 
 Frankhauser and his associates Vander Zypen, Babie and 
Loertscher worked first with a Q-switched neodymium glass and 
subsequently with Q-switched  Nd:YAG lasers.They coupled 
high-energy delivery system and used this device for cutting a 
variety of intraocular membrances
2
. 
 Aron Rosa recognized the utility of Nd:YAG laser 
photodisruption for posterior capsulotomy in Oct 1978. 
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LASER FUNDAMENTALS 
Properties of Laser light 
Monochromaticity: Lasers emit light at only one wavelength or at 
combination of several wavelengths that can be separated easily. Thus a 
pure or monochromatic beam is obtained. It can be used to enhance 
absorption by a target tissue and another useful property is that chromatic 
aberration in lens system can not occur. 
Directionality: Lasers emit a narrow beam that spreads very slowly. 
Lasers amplify only those photons that travel along a very narrow path 
between two mirrors. Beam divergence is the physical measurement of 
directionality of the light beam. It is expressed in milliradians (mrad). A 
typical laser has a beam divergence of 1 mrad – it means that the beam 
increases by about 1mm in diameter for every meter traveled. 
Directionality makes it easy to collect all of the light energy in a simple 
lens system and to focus this light to a small spot. 
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Coherence:Extent to which the electromagnetic field of light wave varies 
regularly and predictably in time and space. Laser light projected on to the 
rough surface has a characteristic sparkling quality known as “laser 
speckle‟. 
Polarisation:It is incorporated in the laser system to allow maximum 
transmission through laser medium without loss caused by reflection. 
Brightness and intensity:Radiometry is measurements of electromagnetic 
radiation. Radiant energy is measured in joule (j) and radiant power is 
measured in watt (w). 
Intensity is the power in a beam of given angular size and brightness is the 
intensity per unit area. The laser output is quantitated in either Joules or 
Watts. 
Laser Sources 
Solid – State laser sources: Ruby , Nd:YAG & Diode  
Gas – laser sources : Argon, Krypton,  carbondioxide & Eximer 
laser(Helium & Flourine gas) 
9 
 
MECHANISM OF LASERS 
Optical Breakdown, plasma formation and 
photodisruption 
Optical breakdown is a nonlinear effect achieved when laser light is 
sufficiently condensed in time and space to achieve high irradiance or 
density of power. Optical breakdown is a sudden event that is visibly 
manifested by a spark and accompanied by an audible snap with 
dramatic damage to the target. It produces an ionized state called as 
plasma. Light energy can create plasma when high irradiance is 
achieved, commonly between 10
10  
and 10
12
 watts/cm
2
. 
Ionization: 
2 different mechanism for optical breakdown by „Q- switched‟ and 
„Mode locked‟ Nd:YAG laser1. 
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„Q – switched‟ pulses cause ionization mainly by focal heating of target 
termed as thermionic emission. „Mode-locked‟  pulses by multiphoton 
ionization. 
 
Growth: 
A free electron absorbs a photon and accelerates. The accelerated 
electron strikes another atom and ionizes it resulting in two free 
electrons each with less individual energy. These two free electrons 
absorb more photons, accelerate, strike other atoms and release two 
more electrons and so forth. The process of photon absorption and 
electron acceleration in the presence of atom or ion is technically 
known as inverse „breamsstrahlung‟ 
Plasma shielding: 
Once formed, plasma absorbs and scatters incident light. This property 
shields underlying structures that are in the beam path. In addition to 
absorption, plasma scatters light by a process known as Brillouin 
scattering and stimulated Brillouin scattering. In “Stimulated  
11 
Brillouin”, the light is scattered by thermally excited waves and shifted 
in a frequency equal to the frequency of photons characteristic of the 
material. In stimulated Brillouin scattering, which occurs at higher 
irradiance, the laser itself creates the acoustic wave that scatters it. 
 
Mechanism of damage: 
Focal Thermal   Protein Denaturation 
Effects   Melting 
       Vaporication 
       Thermal expansion   Acoustic 
             & shock  
              waves 
High Irradiance  Optical breakdown      Plasma expansion 
Laser pulse   &          Stimulated 
    Plasma formation   Brillouin scattering 
                Radiation pressure 
 
                                 
                              Strong 
                                  Electromagnetic 
                                                      Field 
                                                                            Electrostriction 
Thermal mechanism: 
The microplasma temperature reaches 15,000°c locally. Vaporization 
and melting of liquids and solids occur in a small volume near the focal  
12 
point. In biological systems, thermal denaturation of protein and 
nucleic acids is calculated to be confined to a radius of 0.1 mm for a 1 
mj pulse. 
Pressure waves: 
Several mechanisms may combine to generate pressure waves radiating 
from the zone of optical breakdown. Among these, the rapid plasma 
expansion begins as a hypersonic shock wave. A second weaker source 
of hypersonic and sonic waves is stimulated  Brillouin  scattering, in 
which the laser light generates the pressure wave that scatters it. The 
focal heating can lead to phase change (vaporization and melting) and 
thermal expansion both of which generates acoustic waves. The electric 
field of laser light, if sufficiently strong will deform a target through 
electrostriction (mechanism that leads to simple Brillouin scattering) 
and through radiation pressure caused by momentum transfer from 
photons to atoms during inverse bremsstrahlung. 
The shock wave is followed by cavitation or vapor bubble formation. 
Cavitation begins within 50 o 150nsec after breakdown in water. It  
13 
expands rapidly for the first 20µs and reaches a maximum size of about 
0.6 mm at 300µs. Finally it collapses within 300 to 650µs. Cavity 
propagation velocity is approximately 20m/sec at point 300µ from the 
breakdown. Cavitation is too rapid to be visible and should be 
distinguished from bubble formation. Persistent bubbles probably 
consist of hydrogen and oxygen gas. 
 
Spark Emission: 
The visible spark represents the release of energy as photons, when 
electrons recombine with ions (bremsstrahlung). The emission has a 
blackbody-like spectrum including  the visible ultraviolet and in some 
materials the near x-ray wave lengths. The spark is a useful marker of 
the zone of optical breakdown.  
 
 
 
 
14 
Nd:YAG LASER-SYSTEM CONFIGURATION 
The design of ophthalmic laser system for posterior capsulotomies 
begins with the choice of laser source. Following Table shows key laser 
parameters for both „Q-switched‟ and „Mode locked‟ Nd:YAG laser 
and compares them with an Argon photocoagulator. 
Laser  
Parameters 
Argon 
Photocoagulator 
Nd:YAG 
Q-switched 
Nd:YAG 
Mode locked 
Wave length (mm) 488 – 545 1064 1064 
Energy dose (mj) 50 – 500 4 – 15 3 – 6 
Pulse duration (sec) 0.01 – 1.0 10-8 10-11 
Peak power (W) 2 106 108 
No. of Shots 1 – 100 1 – 20 1 – 50 
Spot size on target (mm) 0.1 – 1 0.05 0.05 
 
Difference between „Q-switched‟ and „Mode locked‟ lasers is in the 
method pulsing the laser. „Q-switched‟ units use an electronic shutter 
called as pockel‟s cells and generate a pulse of 10-20 nanosecond 
width. „Mode-locked‟ units use a passive dye cell. Since the dye cells 
age and ultimately become ineffective, the dye in a mode locked  
Nd:YAG system must be changed periodically. 
  
 
 
 
 
 
 
 
 
 
15 
 Nd:YAG laser 
 He: Ne guide laser 
 Beam expanding optics 
 Slit Lamp for delivery of beam 
 Mechanism for delivering the beam from the lasers to 
 moving slit lamp 
 Electronics including laser power supplies 
 Long Laser energy monitoring devices 
 Safety interlock 
 Suitable housing 
 
Upon power up, all interlocks are activated and shutters closed. The 
Nd:YAG lasers may be fired (with the shutter closed) to verify the output 
power setting and He: Ne shutter maybe opened to allow visualization of 
the aim point of Nd:YAG beam. The Nd:YAG shutter may be opened and 
the Nd:YAG laser may be fired. The Nd:YAG beam is directed by mirrors 
to the slit lamp assembly where it is expanded using a Galilean telescope 
to obtain a diameter sufficient to create  a low f-number and corresponding 
small spot size inside the patient‟s eye. The He: Ne beam travels in co-
axial Path and can be used to locate aim point of Nd:YAG laser visually. 
The slit lamp is operated normally. Some systems provide independent 
adjustment of slit lamp illumination source from the laser, allowing  
improved visualization of ocular structures. The physician‟s eyes are 
protected by a band-reject filter at the Nd-YAG wavelength of 1064nm. 
 
 
Nd : YAG LASER INSTRUMENT 
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POSTERIOR CAPSULAR 
OPACIFICATION 
Postoperative opacification of initially clear posterior capsules occurs 
frequently in patients after extra capsular cataract extraction. 
In adults, the time from surgery to visually significant opacification varies 
from months to years and the rate of opacification declines with increasing 
age. In younger age groups, almost 100% opacification occurs within 2 
years after surgery
9
. 
Incidence: 
Varies with different studies. 
Sinskey and Cain study- 43% in 26 months follow up. 
Emery study – opacification in 28% with 2-3yrs follow up. Late 
opacification of posterior capsule after 3-5 years has been reported to be 
approximately 50%
9
. 
 
 
 
 
 
 
  
ELSCHNIG’S  PEARLS 
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PHOTOLOGY OF CAPSULAR OPACIFICATION 
Posterior capsular opacification occurs as a result of formation of 
opaque secondary membranes by active lens epithelial proliferation, 
transformation of lens epithelial cells into fibroblasts with contractile 
elements and collagen deposition
9,13
. The anterior lens epithelial cells 
proliferate onto the posterior capsule at the site of apposition of anterior 
capsular flaps to the posterior capsule. The contraction caused by the 
myoblastic features of lens epithelial cells produces wrinkling of the 
posterior capsule. Collagen deposition results in white fibrotic 
opacities
30
. 
Clinically, optical degradation of initially clear posterior capsule takes 
several forms. Fibrosis is one form characterised by the gray white 
band or plaque-like opacity
9
. It is usually seen in early postoperative 
period or may occur late. Fibrosis that is present in the first days to 
weeks postoperatively most often represents cortical lamellae left at the 
time of surgery. Fibrosis that develops months to years postoperatively 
is caused by migration of anterior lens epithelium, fibroblastic  
 APHAKIA WITH   P.C.O. 
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metaplasia and collagen production
13
. Formation of small Elschnig 
pearls and bladder cells, second major form of opacity, occurs months 
to years after surgery. This opacity occurs from proliferating lens 
epithelial cells, which can form layers, several cells thick. 
Capsular wrinkling has two manifestations. Broad undulations of clear 
capsule are common in early postoperative period. Posterior chamber 
lens haptics may induce these broad wrinkles along the axis of haptic 
orientation. Fibrotic contraction can also lead to wrinkles. Broad 
undulating wrinkles of clear capsule are rarely disturbing to the 
patient
9
. 
In contrast, fine wrinkles caused by myoblastic differentiation can 
result in marked optical disturbance. These fine wrinkles are caused by 
myofibroblastic differentiation of the migrating lens epithelial cells, 
which acquire contractile properties resulting in the wrinkles
13
. 
If the iris forms synechiae to the capsule, reactive pigment epithelial 
hyperplasia and migration onto the capsule may occur. Most often these 
adhesions occur if large amount of cortex are left at time of surgery – 
common in traumatic cataract. Localised pigmented precipitates on the 
capsule and intraocular lens can occur spontaneously or after 
hemorrhage or inflammation. 
 
 
 
 CAPSULAR  THICKENING  THROUGH  SLITBEAM 
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Nd:YAG LASER POSTERIOR CAPSULOTOMY 
 
INDICATIONS: 
Nd:YAG posterior capsulotomy is indicated for opacification of the 
posterior capsule resulting in decreased visual acuity for the patient. 
Careful assessment is necessary to be certain that posterior capsule 
opacification is the cause for decreased visual acuity
29
.  
CONTRAINDICATIONS: 
Absolute Contraindications 
 Corneal scars, irregularities or edema that interferes with target 
visualization and makes optical breakdown unpredictable
31
. 
 If the patient proves unable or unwilling to fixate adequately with 
the threat of inadvertent damage to adjacent intraocular 
structures. 
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Relative Contraindications 
 Glass intraocular lens because of possibility of causing complete 
fracture in the glass optic. 
 Known or suspected   Cystoid macular oedema. 
 Active intraocular inflammation until the visual impairment 
becomes functionally unacceptable to the patient. 
 High risk for retinal detachment33. 
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TECHNIQUE 
 
Preoperative Assessment 
All patients require complete ophthalmic history and examination 
before treatment. It includes  
 Notation of medical History, topical and systemic medications. 
 Vision 
 Intraocular pressure of both eyes. 
 Slit lamp examination. 
 Fundus examination. 
Judging the contribution of a capsular opacity to the patient‟s 
overall visual deficit may be difficult. Following techniques are 
useful for the assessment of capsular opacity. 
 Direct ophthalmoscopic visualization of fundus structures since 
the visibility of retinal details correlates with patient‟s view of the 
world. 
 Retinoscopy 
 
22 
 Red reflex evaluation by: 
– Slit lamp examination. 
– Direct ophthalmoscopic examination. 
– Indirect ophthalmoscopic examination.  
 Laser Interferometer 
 Potential acuity meter – helps to assess the macular function 
 Fluorescein angiography – when capsular opacity seems 
inadequate to explain quality of vision, FFA has to be done to 
rule out Cystoid  macular oedema. 
Preparation of the patient 
The purpose and nature of the procedure should be explained to the 
patient and informed consent obtained beforehand. At the time of 
treatment,  the patient is reassured by the familiar appearance of slit 
lamp delivery system. The surgeon should remind the patient that the 
procedure is painless. The patient may hear small clicks or pops, but 
the patient must simply maintain steady fixation. The procedure is 
completed in a matter of minutes
2
. 
23 
Apraclonidine or beta-blocking agent should be administered in the eye 
1 hour prior to and immediately upon completion of Nd:YAG laser 
procedure to minimize a postoperative intraocular pressure spike. 
Dilatation of pupil facilitates visualization of the capsule over a broad 
expanse. It is helpful for a surgeon inexperienced with laser 
capsulotomy. In the absence of miotic pupil, dilation may be omitted 
when an experienced  surgeon is performing the procedure. 
If the pupil is to be dilated, the landmarks of the pupillary zone of the 
capsule should be sketched. Inattention to the pupillary zone may result 
in an eccentric capsulotomy. The patient can be brought to the laser  
before dilatation and a single marker shot can be placed in the capsule 
near the middle of pupillary axis. For routine dilatation, a single drop of 
2.5% phenylephrine or 0.5% tropicamide may be used. 
No anaesthesia is generally required for capsulotomy unless contact 
lens is employed. If the contact lens is used, topical anaesthetic drops to 
be applied. The patient must be seated comfortably with properly 
adjusted stool, table, chin-rest heights and footrests. A Strap that passes 
from the  
24 
headrest behind the patient‟s head is useful to counteract the tendency 
of many patients to move back during the course of treatment. The 
surgeon‟s visualization of the target is usually improved in a darkened 
room. If the patient is expected to fixate with other eye, an illuminated 
fixation target should be provided. 
PROCEDURE 
A contact lens such as the peymen or central Abraham lens may be 
used to stabilize the eye, improve the laser beam optics and facilitate 
accurate focussing.  The Abraham lens increases the convergence angle 
to 24° from 16°, decreases the area of laser at the posterior capsule to 
14µg from 21µg and increases the beam diameter at both the cornea 
and retina
1
. 
Minimum amount of energy is desired to rupture the capsule. 
With most lasers, a typical capsule can be opened by using 1 to 2 
mj/pulse. 
The capsule is examined for wrinkles that indicate tension lines. Shots 
placed across tension lines result in the largest opening per pulse. 
 PERFORMING   YAG LASER  CAPSULOTOMY 
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The usual strategy is to create a cruciate opening beginning superiorly 
near 12 o‟clock position. Unless a wide opening has already developed, 
shots are then placed at the edge of capsule opening, progressing 
laterally towards 3 o‟clock and 9 o‟clock position. If any capsular flaps 
remain in the pupillary space, the laser is fired specifically at the flaps 
to cut them and cause them to retract and fall back to the periphery.  
The goal is to achieve flaps based in the periphery inferiorly. Floating 
fragments should be avoided because they may remain and cause visual 
interference
1
. 
Beginning the cruciate opening in the superior periphery has several 
advantages. The initial shots are in the periphery so that if the patient 
becomes startled and an adjacent intraocular lens is marked, the mark 
appears in the periphery. Both patient and surgeon can have settled 
down before more critical central area is treated. Furthermore, as the 
flap develops, gravity aids in pulling them towards the inferior 
periphery. In contrast, it can be very difficult to cause a flap hanging 
down from above to retract. 
Following techniques are used to minimize intraocular lens marks 
 AFTER LASER CAPSULOTOMY 
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 Use minimum energy 
 Use a contact lens to stabilize the eye, improve the laser beam 
optics, and facilitate accurate focusing. 
 Identify any areas of intraocular lens-capsule separation and 
begin treatment there. 
 If lens marking is occurring, make an opening in the shape of a 
Christmas tree from 12o‟clock to the 4.30 o‟clock position and 
from the 12 o‟clock to the 7.30 o‟clock position without planning 
any shots in the central optical zone. 
 Use deep focus techniques: optical breakdown occurs in the 
anterior vitreous and the shock wave radiates forward and 
ruptures the capsule. High energy (2mj) must be used
11
. 
Capsulotomy size: 
The capsulotomy should be as large as the pupil in ambient light. A 
small opening in a dense membrane results in excellent optics. But 
when the capsule is only hazy and transmits image to the retina, that 
mixes with the image transmitted through clear, opening and the patient 
may experience symptoms of glare or decreased contrast sensitivity
2,6
.  
27 
A capsule with residual haze not only impairs vision under standard 
conditions but also produces glare. A clinical study by Steinert & 
Puliafito demonstrated that the glare and haze continue to be a problem 
for 1-2mm capsular opening, decrease with 3mm opening and fully 
resolve only with a 4mm capsular opening.  
Post operative care 
After  capsulotomy, apraclonidine or a betablocker should again be 
administered topically to minimize intraocular pressure rise
9,20
. For 
high-risk patients, intraocular pressure is measured again 1hour 
following laser treatment. If the patient has significant preexisting 
glaucomatous disc damage or intraocular pressure is increased by 5mm 
Hg or more at 1  hour, the intraocular pressure should also be 
remeasured at 4 hours.  
An increased intraocular pressure may be treated with apraclonidine, 
betablocking drugs, topical pilocarpine, systemic carbonic anhydrase 
inhibitors and hyperosmotic agents
21,22
. If the intraocular pressure has 
increased following posterior capsulotomy, antiglaucoma therapy 
should be continued for atleast 1wk to prevent delayed pressure 
elevation. IOP should be again measured after 1 wk. 
28 
Treatment following laser therapy with topical steroids and cycloplegic 
agents varied widely according to the individual surgeon‟s experience. 
Since few patients experience iritis, some surgeons favour topical 
steroids 4 times daily for 1
st
 postoperative week and then taper the 
steroid drops gradually. 
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COMPLICATIONS 
Intraocular pressure elevation: 
Most  common complication following Nd:YAG laser capsulotomy – 
usually transient. The IOP typically begins to rise immediately 
following laser capsulotomy, peaks at 3 to 4 hours, decreases but may 
remain elevated at 24 hours and usually returns to baseline at 1 week. 
Rarely IOP may remain persistently elevated, causing visual field loss 
or requiring glaucoma surgery. The elevated IOP following Nd:YAG 
laser posterior capsulotomy has been associated with preexisting 
glaucoma, capsulotomy size, lack of posterior chamber intraocular lens, 
laser energy required for capsulotomy, myopia and preexisting 
vitreoretinal disease
20,21,22
.   
Increased IOP following capsulotomy is associated with a reduced 
facility for aqueous humor outflow. This reduced facility has been 
attributed to capsular debris, acute inflammatory cells, and liquid 
vitreous and shock wave damage to the trabecular meshwork. 
Laboratory studies have demonstrated pigment granules, erythrocytes, 
fibrin, lymphocytes and macrophages within trabecular meshwork after  
30 
laser capsulotomy supporting the proposal that acute inflammatory 
cells and capsular debris are the cause of increased intraocular pressure. 
Eyes with preexisting glaucoma have an increased frequency and 
magnitude of intraocular pressure elevation following laser treatment 
because the glaucomatous eyes already  have a reduced outflow facility 
and further obstruction of trabecular meshwork results in marked 
intraocular pressure increase
21
. Liquid vitreous  as the cause of outflow 
obstruction has been supported by the clinical association between 
increased IOP following laser treatment and myopia, preexisting 
vitreoretinal disease, large capsulotomy, lack of posterior chamber 
intraocular lens and sulcus fixated posterior chamber intraocular lenses. 
A capsule fixated posterior chamber intraocular lens and a smaller 
capsulotomy may provide a barrier effect preventing liquid vitreous 
from reaching the anterior chamber and trabecular meshwork
20,22
. 
Nd:YAG induced shock wave causing increased intraocular pressure 
resulting in damage to the trabecular meshwork is supported clinically 
by the association between increased intraocular pressure and higher 
total laser energy used to create the capsulotomy
21
. 
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Since increased intraocular pressure is common complication following 
laser therapy and can result in permanent loss of vision, prevention of 
IOP rise is important. Apraclonidine, timolol, levobunolol, and 
pilocarpine have been shown to decrease the frequency and magnitude 
of IOP increase following laser treatment. These drugs are 
administrated 1 hour prior to Nd:YAG laser posterior capsulotomy and 
again following the procedure. Patients at high risk for IOP elevation 
should be carefully monitored following laser capsulotomy
22
. 
The IOP following laser capsulotomy may also be elevated by vitreous 
obstruction of sclerostomy, the development of neovascular glaucoma 
or pupillary block glaucoma
20
. 
Cystoid macular oedema 
It has been reported to develop in 0.55-2.5% of eyes following 
Nd:YAG laser posterior capsulotomy
28
. It may occur between 3 weeks 
and 11 months following capsulotomy. One prospective study provides 
evidence that incidence of new Cystoid macular oedema is low 
following laser capsulotomy, although some patients may acquire 
Cystoid macular oedema during prolonged follow-up study. Stark and  
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colleagues concluded that the risk of Cystoid macular oedema could be 
lowered by a long interval between extracapsular cataract extraction 
and laser capsulotomy
28,33
. 
 
Retinal Detachment 
Retinal detachment may complicate Nd:YAG laser capsulotomy in 
0.08% to 3.6% eyes
33,34
. A retinal detachment may occur early after the 
laser capsulotomy or more than a year later. Myopia, history of retinal 
detachment in other eye, younger age, and male sex are risk factors for 
retinal detachment following YAG laser capsulotomy. 
Intraocular lens damage 
Pitting of intraocular lenses occurs in 15% to 33% of eyes during 
posterior capsulotomy
6,11
. The pitting usually is not visually significant, 
although rarely the damage may cause sufficient glare and image 
degradation that the damaged intraocular lens must be explanted. The 
type and extend of lens damage is dependent upon the material used in 
the intraocular lens
6,11
. Glass intraocular lens may be fractured by  
 LASER MARKINGS  OVER  IOL 
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Nd:YAG laser, polymethyl methacrylate intraocular lenses sustain 
cracks and central defects with radiating fractures. Moulded polymethyl 
methacrylate lenses are more easily damaged than higher molecular 
weight lathe-cut lenses. Damage to silicon lenses is characterized by 
blistered lesions and localised pits surrounded by multiple tiny pits. 
The frequency of lens damage is dependent upon the intraocular lens 
style. Intraocular lenses designed with a ridge separating posterior 
capsule from intraocular lens sustain less damage than lenses with a 
convex posterior surface and close apposition between posterior 
chamber intraocular lens and posterior capsule
3
. 
Endophthalmitis: 
Several cases of propionibacterium acnes Endophthalmitis have been 
reported following capsulotomy. Eyes develop significant uveitis and 
loss of vision. Presumably the capsulotomy created an opportunity for  
the organisms sequestered within the capsule to reach the vitreous and 
develop into endophthalmitis
5
. 
 
34 
Other complications 
 Iritis-less than 1% eyes 
 Macular Holes-rare4 
 Corneal endothelial cell loss-2.3 to 7% 
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REVIEW OF LITERATURE 
1) Nd:YAG laser posterior capsulotomy-first 100 cases at UCLA 
Kathym M. Gardner, Bradley R. Straatsma: J Ophthalmic Surgery 
1985; 16. 
Initial anatomic success was reported in 97% of the first 100 
Neodymium YAG laser posterior capsulotomies performed at the Jules 
Stein eye institute. Visual acuity improved in 90 patients. It was 
unchanged in five patients and decreased in five patients. In the five 
patients, with decreased visual acuity after posterior capsulotomy, the 
decrease was unrelated to capsulotomy and caused by progression of 
preexisting retinal disease. 
 
2) 3000 YAG lasers in posterior capsulotomies: An analysis of 
complications R.Shah, P. Gills and associates- J Ophthalmic 
Surgery 1986:17;473 Visual acuity improved to 20/40 – 20/20 
group in 89.9%of subjects. IOL markings occurred in 12%. 
Transient elevation of IOP occurred in 8.5%. Cystoid macular  
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oedema – 0.68%. Retinal detachment – 0.17%. Hyphema 0.15%. 
Iritis – 0.1%  
 
3. Evaluation of visual function following ND:YAG laser 
posterior capsulotomy. Datiles MB, Lasa MS : J. Ophthalmolgy 
1997 Aug :104; 1287 – 93. 
 
The authors analysed 24 consecutive patients before and after 
Nd:YAG laser posterior capsulotomy. In addition to the 
measurement of visual acuity, they also analysed the contrast 
sensitivity and glare disability. Results: Mean differences between 
pre-laser and post-laser measures were significantly different from 
zero. (1) contrast sensitivity, mean difference  = 0.24 log units (p < 
0.0001). (2) High glare disability using pelli- Robson chart, mean 
difference = 0.15 log units (p = 0.004); (3) visual acuity using 
ETDRS chart mean difference = 11 letters (p=<0.0001). ND:YAG 
laser capsulotomy is shown to significantly improve visual acuity, 
contrast sensitivity  and glare disability. 
 
37 
 
4. Intracular pressure changes after Neodymium YAG capsulotomy  
Howver RR, Marefat B: J.cataract Refract surg 1997, Jan- feb 23:115- 
20. 
This study comprised 101 eyes. All patients received  1 drop of 
apraclonidine HCl 0.5%   30 to 60 min before and then after Nd: 
YAG capsulotomy. Intraocular pressure was measured  
preoperatively and at 1hr, 24 hrs, 1 week and 1 month 
postoperatively. Results: within 24 hours after capsulotomy, no 
significant  IOP elevations  occurred. There was  one  case  of  
modest  IOP elevations at 1 week, none was seen at 4 weeks.  There 
was no relation between change in IOP and number of laser pulses, 
energy  per   pulse  or  total energy. 
5. C.A.G.M. vester, M.F. Bienfait, P.T.V.M. de jong Erasmas  iversity. 
Eye Hospital,  schiedamsevet 545 causes, inevidence 1.1%,    follow 
up > 6 months  
6.  Retinal  detachment  after  posterior  capsulotomy with YAG  laser 
    Hallaq  E,Montard  M.; J  Fr  Ophthalmol   1995 : 18:  733 - 45.  
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    24 cases were analysed  to determine  risk factors , etiology, 
management and prognosis. RD was total or subtotal  in  25 % of cases.  
The macula was detached  in  58%.  Anatomic  success  was achieved 
in 88% of cases. The  proliferative vitreoretinopathy was the main 
cause of   recurrence. 
7. Incidence of retinal detachment after cataract surgery and Nd :YAG 
laser capsulotomy. Powell SK, Olson RJ; J. cataract refract Surgery 
1995, Mar:21:132-5. 
This study comprised of 1092 patients, who had cataract extraction, Of 
1092, patients ,  215  had  Nd:YAG laser capsulotomy.    The incidence 
of   RD  following phacoemulsification alone was 0.75% with a mean 
time between cataract extraction and  RD  of 11.6 months. The 
incidence of RD following ND:YAG laser capsulotomy was 0.82% 
(2/244) with a mean time of 32 months between cataract surgery and 
capsulotomy and 13.5 months between capsulotomy and RD. This 
study confirms the increased risk of RD following posterior capsule 
rupture and anterior vitrectomy. 
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8. The  barrier function in Neodymium – YAG laser capsulotomy; smith 
RT Moscoso WE; Arch Ophthalmol, 1995: May 113:645 – 52. 
21 eyes were analysed to measure the disruption of the anterior – 
posterior extracapsular barrier complex induced by Nd:YAG laser 
capsulotomy and to determine how it might be minimized. Results 
showed that both anterior vitreous disruption and absence of posterior 
chamber IOL were significantly correlated with loss of barrier 
efficiency and glaucoma occurred more frequently when barrier 
efficiency was lost postoperatively. 
9. Chaudhary M et al 
Nepal J. Ophthalmol 2011; 3(5): 80-82. A rare complication of Nd-
YAG laser capsulotomy: propionibacterium aenes endophthalmitis. 
They come across one case recently  and may be due to breakdown of 
barrier. 
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MATERIALS AND METHODS 
This prospective clinical study was done to analyse the results of 
Nd:YAG laser posterior capsulotomy in posterior capsular 
opacification following cataract surgery. This study was carried out at 
Government Rajaji Hospital, Madurai. 
Eyes of 100 patients who underwent YAG laser posterior capsulotomy 
were studied. 8 patients were aphakic; 89 patients had posterior 
chamber intraocular lens and 3 patients had anterior chamber 
intraocular lens. Informed consent was obtained from all patients. 
Following data was collected from each patients. 
 Age and sex 
 Date of cataract surgery 
 Presence and type of Intraocular lens 
 Current eye medications & systemic medications 
 Best corrected visual acuity with glasses by using Snellen chart. 
 Anterior segment examination with oblique illumination and then 
with slit lamp examination. 
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 Intraocular pressure measurement with Schiotz tonometry  
 Fundus examination with direct ophthalmoscopy and indirect 
ophthalmoscopy if necessary. 
The posterior capsulotomies were performed with Nd:YAG laser, usually 
starting with 1 – 2 mj / pulse and gradually increased until the desired 
responses were obtained. 
Following points were noted: 
 Pulse energy, number of pulses 
 Operative complications 
Immediately after capsulotomy, timolol 0.5% eye drops was applied to 
each patient and tablet acetazolamide 250mg twice a day was given. 
Antiglaucoma medications were continued depending upon the intraocular 
pressure changes during follow up period. Steroid eye drops were 
prescribed for all the patients for 1 week after the capsulotomy. Post laser 
follow up was done after 1 hour, 24 hours, 1 week, 1 month and 3 months. 
During each visit, following data was recorded. 
 Visual acuity with Snellen chart 
 Intraocular pressure with Schiotz tonometry 
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 Slit lamp examination 
 Fundus examination with direct and indirect ophthalmoscopy 
 Post laser complications 
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OBSERVATIONS AND RESULTS 
 
Total number of patients – 100 
RE – 45 eyes 
LE – 55 eyes 
Table 1. Age Distribution 
 
 
 
 
 
Table 2. Sex distribution 
 
 
 
Age Cases 
1 to 20 5 
21 to 40 6 
41 to 60 45 
>60 44 
Sex Cases 
Males 46 
Females  54 
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Table 3: Type of surgery 
 
 
 
 
 
 
Table 4: Time Interval between cataract surgery and development of 
posterior capsular opacification. 
 
 
 
 
 
 
 
Types of Surgery Cases 
PI.E.C.C.E 8 
PC IOL 89 
AC IOL 3 
Duration Cases 
6 months – 1 year 44 
>1 year-1
1/2
years 29 
>1
1/2
years -2 years 17 
>2 year-2
1/2
years 4 
2
1/2
years- 3 years 4 
>3 years 2 
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44% cases of posterior capsular opacification were noted between 6 
months to 1 year after cataract surgery. 29% of cases were noted 
between 1 to 1
-1/2
 years after cataract surgery. 2 cases of posterior 
capsular opacification were noted after 3 years – one at 3 ½ years and 
another case at 4 years after cataract extraction. Cases, which had 
developed posterior capsular opacification within 3 – 6 months 
following cataract surgery, were advised to come after 6 months and 
posterior studies report a less incidence of complications when laser 
capsulotomy was done after a longer interval following cataract 
surgery. 
Table 5: Laser power distribution 
 
 
 
 
 
 
Total Energy (mj) Cases 
10 to 20 29 
21 to 40 34 
41 to 60 26 
61 to 80 7 
81 to 100 3 
>100 1 
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The posterior capsulotomies were performed with Nd: YAG laser 
starting with 1 – 2 mj/pulse and gradually increased until the desired 
response were obtained. In most cases, desired response was obtained 
within the total energy of 50 mj. However, in certain cases, more than 
100 mj were used because of thick posterior capsule. 
Table 6: Pre laser visual capsule 
 
 
Table 7: Post laser visual Acuity improvement. 
 
 
 
 
 
 
Visual Acuity  <3/60 6/60 – 3/60 6/18 -6/36 
Cases 10 75 15 
Follow up  <3/60 6/60 – 3/60 6/18 -6/36 6/6 – 6/12 
1 Hr. 4 12 57 27 
24 Hrs. 4 10 45 41 
1 week 4 1 39 56 
1 month 2 2 31 65 
3 months 2 2 30 66 
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Visual acuity profile reveals that 75% of patients had visual acuity in 
the range between 6/60 to 3/60 and 10% of patients had visual acuity 
less than 3/60 before doing YAG laser posterior capsulotomy. 
Immediately after doing YAG laser capsulotomy within one hour, 57% 
of patients had improved visual acuity of 6/18 to 6/36 and 27% patients 
had better visual acuity of 6/6 to 6/12. The percentage of patients with 
better visual acuity had increased gradually during follow up period – 
at 24 Hours, 1 week, 1 month and 3 months. At the end of 3 months, 
66% of patients had visual acuity of 6/6 to 6/12 and 30% of patients 
had visual acuity of 6/18 to 6/36. The vision of 4% of subjects was not 
improved by laser capsulotomy. Among 4 cases, 2 cases showed optic 
atrophy, one case presented with retinitis pigmentosa with consecutive 
optic atrophy, inability to penetrate thick posterior capsule in one case. 
Table 8: Nd: YAG laser posterior capsulotomy   -  IOP measurement. 
 
 
IOP(mmHg)  Prelaser 1 Hr 24 Hrs 1 week 1 Months 3 Months 
5 to 10 10 5 13 11 10 10 
11 to 15 55 47 47 54 55 55 
16 to 20 35 46 39 35 35 35 
>21  2 1    
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Intraocular pressure was measured at 1 hour, 24 hours, one week and 
three months after Nd:YAG laser capsulotomy. In this analysis, 30% of 
cases showed transient elevation of intraocular pressure, within normal 
range of 20mm Hg. Only 2 cases showed intraocular pressure of more 
than 21 mm Hg. One case showed 30.8 mm Hg at 1 hour and 31.8 mm 
Hg at 24 hours. This patient was treated with timolol 0.5% eye drops 
and acetazolamide tablet 250 mg twice daily for 1 week and at the end 
of 1 week, IOP became normal. Another case showed 30.2 mm Hg at 1 
hour and returned to normal at 24 hours. No case showed increased 
intraocular pressure at 1 week, 1 month and 3 months following 
Nd:YAG laser capsulotomy. 
In 4% of cases, intraocular pressure was reduced to 2-4 mm Hg from 
their preoperative level and returned to normal at 1 week, 1 month and 
3 months follow-up. This decreased intraocular pressure was attributed 
due to application of timolol 0.5% eye drops, immediately after 
capsulotomy. 
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In all cases, timolol 0.5% eye drops was applied immediately after 
procedure and tablet acetazolamide 250 mg twice for 1 day was given. 
Steroid eye drops were prescribed for 1 week. Because of these 
reasons, intraocular pressure was not much raised in this study after    
Nd : YAG laser capsulotomy. 
Table 9:  Complications following Nd   :   YAG laser capsulotomy 
 
 
 
 
 
 
Intraocular pressure elevation more than 21 mm Hg were noted in 2% 
of cases. It was detected at 1 hour and 24 hours after YAG laser 
capsulotomy and they were returned to normal level within 1 week 
after treating with Timolol 0.5% eye drops and tablet acetazolamide 
twice daily. 
COMPLICATIONS Cases 
Intraocular Pressure elevation 2 
Iris bleeding 4 
Intraocular lens damage 23 
Vitreous into Anterior chamber 4 
Uveitis 1 
Cystoid macular oedema 0 
Retinal Detachment 0 
Endophthalmitis        0 
 IRIS   BLEEDING 
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DISCUSSION 
The documented visual improvement of the subjects in this study 
confirms the efficacy of Nd:YAG laser for the production of posterior 
capsulotomy. This noninvasive surgical laser allows omission of 
primary intraoperative capsulotomy, with its increased risk of 
intraocular lens and vitreous displacement, cystoid macular oedema and 
retinal detachment. In this report, the results of present study are 
compared with previous studies. 
M.Gardner, R.Straatsma (1985) analysed 100 cases of ND:YAG laser 
posterior capsulotomy. They reported that 48% increase in the number 
of subjects with 20/15 to 20/40 vision at 24 hours. At one week, 73% of 
entire population was in the 20/15 to 20/40 group and the 29% initially 
in the 20/200  –  20/400 group had dropped to 1%. The vision of 5% 
subjects was not improved by laser capsulotomy due to documented 
progression of preexisting retinal disease. 
Dick B, Scheween O (1997) stated that visual acuity improved in 
93.6% of cases. 
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In our study, 96% of subjects showed significant visual acuity 
improvement. At 24 hours after capsulotomy 27% of patients had the 
visual acuity of 6/6 to 6/12 and at 3 months it was increased up to 66%. 
75% of patients initially with visual acuity of 6/60 to 3/60 (prelaser) 
had dropped to 2% after capsulotomy. The vision of 4% of subjects was 
not improved by laser capsulotomy. In this, 2 patients had optic 
atrophy, 1 patient had retinitis pigmentosa with consecutive optic 
atrophy. One patient, who underwent IOL implantation following 
traumatic cataract, developed thick posterior capsular opacification, 
which could not be penetrated even with maximum energy of 220mj 
done twice. Posterior capsulotomy was done for 5 cases of intraocular 
lens implantation following traumatic  cataract- vision improved in 4 
cases. 
Gardner and associates (1985) reported that the percentage of subjects 
in the > 20 mm Hg group increased 20% from 8.4% preoperatively to 
28.4% at 24 hours. At 24 hours, 23% of subjects demonstrated a >5 
mm Hg increase in IOP over preoperative levels, 11%   >10 mm Hg 
and 5%     >20 mm Hg.  
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Dick B(1997) analysed 31 cases and intraocular pressure rise was noted 
in only one case. 
In present study, 2% of subjects showed increased intraocular pressure 
more than 21 mm Hg. The IOP returned to the normal level within 1 
week. However, transient elevation of IOP of 3-5 mm Hg from their 
basal level was noted in 30% of subjects within 24 hours but not 
exceeding 20 mm Hg. The most likely mechanism for acute pressure 
elevation is trabecular blockage by capsular and cortical debris. In this 
study group, timolol 0.5% eye drops was applied immediately after the 
procedure and tablet acetazolamide twice a day was given to all patient. 
So that, lower incidence of intraocular pressure elevation was noted in 
this present study. 
Although the actual and theoretical advantages of Nd:YAG laser 
capsulotomy is impressive, its use has been associated with both 
intraoperative and postoperative complications. 
Gardner (1985) reported 3% incidence of Iris bleeding with resulting 
minimal hyphema. 
57 
Gardner reported that 4% of study subjects required a second Nd:YAG 
procedure because of inadequacy or closure of capsulotomy. 
In present study, a second Nd:YAG procedure was done in 4% of study 
subjects because of inadequacy. Except one, other 3 cases showed 
improved visual acuity after repeat capsulotomy. In some cases, the 
need for a second procedure might be avoided by careful preoperative 
capsular drawings with documentation of visual axis. 
Terry Ac, Apple DJ (1983) reported intraocular lens damage in 12 of 
30 eyes with intraocular lens implants.  
Gardner (1985) reported 39% of  subjects with intraocular lens damage. 
In present study, intraocular lens pitting was noted in 23 out of 92 
(25%) subjects. Lens pitting is most likely to occur when lens and 
capsule are closely approximately. This had no deleterious effect on 
visual acuity and did not produce the post treatment inflammation that 
might have been expected with release of toxic monomers. However, 
the long-term effects of even minor lens damage with possible release 
of toxic components are not known. Special care should  therefore be 
taken to avoid lens injury. Application of laser energy to a point behind  
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the posterior capsule allows the anterior reflection of shock wave to 
disrupt the posterior capsule rather than the intraocular lens. Use of the 
lowest possible energy in trains of one pulse per burst further decreases 
the risk to the lens. Accurate focus is essential and is aided by use of 
Nd:YAG contact lens. 
Terry  AC, Apple DJ (1983) reported that rupture of vitreous into 
anterior chamber occurred in 6 of 19 eyes without IOL. In present 
study, rupture of anterior hyaloids face with forward displacement of 
vitreous into anterior chamber occurred in 4 out of 8 (50%) subjects. 
Visual improvement in these patients did not seem to be adversely 
affected. We do not know if the anterior displacement of vitreous 
increases the chances of late onset macular oedema or corneal oedema. 
To reduce the chances of rupturing anterior hyaloid face when no 
intraocular lens is present, the laser beam should be focused anterior to 
the capsule and then moves slowly to the posterior. 
Gardner reported postoperative uveitis in 13% of subjects. 
R.Shah,P.Gills  (1985) reported 0.1% subjects of postoperative uveitis. 
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 In present study, postoperative uveitis was reported in 1% of subjects at 
one-week follow up. Inflammation is produced by liberation of large 
amounts of lens cortex into anterior chamber. These patients may benefit 
from perioperative treatment with topical anti-inflammatory agents. Many 
patients with early postoperative aqueous cells and flare appear to have 
persistent suspended capsular debris without a significant inflammatory 
component and can best be managed with observation and monitoring of 
intraocular pressure.  
F. Steinert, Puliafito (1991) reported 11 patients (1.23%) developed 
cystoid macular oedema. 
R. Shah (1985) reported that cystoid macular oedema occurred in 
0.68% of subjects. 
In this study group, no evidence of cystoid macular oedema was noted 
in any patient within 3 months follow-up period. Cystoid macular 
oedema may occur between 3 weeks and 11 months following 
capsulotomy. 
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Stark and colleagues concluded that the risk of cystoid macular oedema 
could be lowered by a longer interval between extracapsular cataract 
extraction and laser capsulotomy. 
Incidence of retinal detachment after Nd:YAG laser capsulotomy in 
various studies is: 
    Aron Rosa, Aron (1984) – 0.1% 
    Stark & associates (1985) – 0.5% 
    Steinert & associates (1991) – 1.23% 
In present study, retinal detachment was not seen in my patients. Two 
proposed mechanisms producing RD include inadvertent production of 
peripheral retinal break and retinal traction caused by vitreous 
displacement. A retinal detachment may occur early after laser 
capsulotomy or more than a year later.  Myopia, a history of retinal 
detachment in other eye,  younger age and male sex are risk factors for 
retinal detachment following Nd:YAG laser posterior capsulotomy. 
Several cases of propionibacterium acnes endophthalmitis have been 
reported following Nd:YAG laser posterior capsulotomy. In this study, 
no case was reported. Following laser capsulotomy, the eyes develop   
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significant uveitis and loss of vision. Presumably, the capsulotomy 
creates an opportunity for the organisms sequestered within the capsule 
to reach the vitreous and develop into endophthalmitis. 
Posterior capsulotomy with Nd:YAG laser offers many advantages 
over primary or secondary surgical capsulotomy. Undesirable 
associated findings can be avoided or minimized through careful 
preoperative evaluation, skilled operative technique and appropriate 
postoperative management. 
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SUMMARY 
1. This clinical study was done at the Department of 
Ophthalmology, Govt. Rajaji Hospital, Madurai. 
2. A total of 100 patients were examined. Out of them 44 were 
males and 56 were females. 
3. 8 patients were aphakic and 92 patients were pseudophakic (89 
had PC-IOL and 3 had AC-IOL). 
4. Nd:YAG laser posterior capsulotomy was done within 6 months 
to 1 year following cataract surgery in about 53 patients.  
5. Posterior capsulotomies were done with minimum laser energy of 
10 mj upto maximum level of 220 mj. 
6. Significant visual improvement was seen in 96% patients; 4 
patients showed no visual improvement, which was related to 
previous retinal problems and  thick posterior capsule. 
7. Transient elevation of intraocular pressure above 21 mm of Hg 
was noted in 2 patients within 24 hours. No case was found to 
have elevated IOP at follow up period (1 week, 1 month and 3 
month). 
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8. Repeat YAG laser capsulotomy was done in 4 patients because of 
inadequacy of previous capsulotomy. Except one, other three 
cases showed improved visual acuity after the repeat YAG 
capsulotomy. 
9. Iris bleeding was noted in 4 patients during the procedure, 
which resolved within one day. 
10. Intraocular lens pitting occurred in 23 patients. 
11. Rupture of anterior hyaloid face with forward displacement of 
vitreous into anterior chamber occurred in 4 patients. 
12. Post –laser uveitis had developed in 1 patient which was 
controlled with steroid eye drops and anti-inflammatory drops 
within 1 week. 
13. No case had been found to develop cystoid macular oedema, 
retinal detachment or endophthalmitis within 3 months follow-
up period. 
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CONCLUSION 
In the past, intracapsular cataract extraction was done for most of the 
patients. Nowadays, most of the ophthalmic surgeons are doing 
extracapsular cataract extraction with intraocular lens implantation. 
Following extracapsular cataract surgery, increased incidence of 
posterior capsular opacification has been noted. The opening of 
posterior capsule by invasive surgical means has been noted to cause 
certain complications such as cystoid macular oedema and retinal 
detachment. The Nd:YAG laser is a noninvasive surgical tool that 
provides excellent posterior capsulotomies. 
From the above study, it is clear that Nd:YAG laser posterior 
capsulotomy is a safe and effective procedure for creating capsular 
opening. The postoperative results are very good and the complication 
rate is low. 
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71 
CLINICAL STUDY - PROFORMA 
Name :      Age:  Sex: 
YAG laser No.  :   O.P/I.P No: 
Laterality   :       RE                   LE 
Type of surgery  :  PI.ECCE/PCIOL/ACIOL 
Date of cataract surgery : 
Prelaser Evaluation  : 
(1)Visual Acuity with correction   : 
(2) Intraocular Pressure     : 
(3) Slit lamp examination     : 
(4) Fundus        : 
Laser setting: 
(1) Energy level  : 
(2) Pulse              : 
(3) No of exposures : 
Post – laser follow – up: 
72 
1 hr     –    Visual Acuity 
     Intraocular pressure 
24 hrs  -      Visual Acuity 
       Intraocular pressure 
      Slit lamp examination 
        Fundus 
1 wk  -   Visual Acuity 
     Intraocular pressure 
     Slit lamp examination 
     Fundus  
1 month -    Visual Acuity 
Intraocular pressure 
     Slit lamp examination 
       Fundus 
3 months - Visual Acuity 
Intraocular pressure 
     Slit lamp examination 
       Fundus 
ABBREVIATIONS 
LASER    – LIGHT AMPLIFICATION STIMULATED EMISION OF RADIATION 
Nd :YAG – NEODYMIUM YITTRIUM ALUMINIUM GARNET 
ECCE  :    EXTRA CAPSULAR CATARACT EXTRACTION 
IOL      :    INTRA OCULAR LENS  
PCIOL:     POSTERIOR CHAMBER INTRAOCULAR LENS 
ACIOL:    ANTERIOR CHAMBER INTRAOCULAR LENS 
IOP      :    INTRAOCULAR PRESSURE 
FFA     :    FUNDUS FLOUREISENCE ANGIOGRAPHY 
RE       :    RIGHT EYE 
LE       :    LEFT EYE 
OP       :    OUT PATIENT 
IP        :     IN PATIENT 
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IOP mj 1 Hr 24 
Hr 
1 
wk 
1 
Mn 
3 
Mns 
1 Hr 24 
Hrs 
1 
Wk 
1 
Mn 
3 
Mns 
 
1 Ayyavu 409091 R 73 M 1 2 6/60 14.6 46 6/24 6/24 6/18 6/18 6/12 14.6 14.6 12.8 14.6 14.6  
2 Kannaian 399011 R 70 M 1 1 2/60 12.8 49 6/60 6/60 6/36 6/36 6/36 14.6 14.6 12.8 12.8 12.8  
3 Shanmugam 408678 L 60 M 1 6/12 6/60 14.6 140 6/24 6/24 6/18 6/18 6/18 17.3 17.3 14.6 14.6 14.6 Multiple IOL markings 
4 Rajammal 484733 R 56 F 1 1
1/2
 1/60 17.3 10 6/12 6/12 6/9 6/9 6/9 17.3 17.3 17.3 17.3 17.3  
5 Lakshmi 446019 L 64 F 1 2 4/60 14.6 12 6/12 6/12 6/9 6/9 6/9 17.3 17.3 14.6 14.6 14.6  
6 Kamatchi 430612 L 48 F 1 1 6/24 12.2 86 6/18 6/18 6/12 6/12 6/12 17.3 14.4 12.2 12.2 12.2 Laser Markings over IOL 
7 Subbaiah 431230 L 65 M 1 8/12 5/60 17.3 150 6/12 6/12 6/12 6/12 6/12 17.3 14.4 14.4 14.4 14.4  
8 Narayanammal 507817 R 63 F 1 10/12 6/60 17.3 40 6/36 6/18 6/18 6/18 6/18 14.4 17.3 17.3 17.3 17.3  
9 Rakku 482093 L 55 F 1 2
1/2
 6/60 17.3 20 6/18 6/18 6/12 6/12 6/12 30.8 31.8 17.3 17.3 17.3 Increased IOP 
10 Banumathi 507916 R 38 F 1 1
1/4
 6/36 12.2 54 6/18 6/18 6/18 6/18 6/18 12.2 14.6 14.6 14.6 14.6  
11 Ayyammal 358066 R 70 F 1 1 4/60 10.2 18 6/60 6/60 6/36 6/36 6/18 10.2 10.2 12.2 12.2 12.2 Laser Markings over IOL 
12 Pechi  Thevar 388695 L 49 M 1 3 6/36 14.6 45 6/18 6/12 6/12 6/12 6/12 14.6 12.2 12.2 12.2 12.2  
13 Subbulakshmi 478738 L 63 F 1 1 6/36 17.3 20 6/24 6/18 6/18 6/18 6/18 14.4 14.4 17.3 17.3 17.3  
14 Neshakirubamani 359032 L 55 F 1 1
1/2
 3/60 17.3 94 6/36 6/12 6/12 6/12 6/6 17.3 17.3 17.3 17.3 17.3  
15 Ammani 482939 R 60 F 1 1 4/60 12.2 84 6/18 6/12 6/12 6/12 6/12 17.3 12.2 12.2 12.2 12.2  
16 Ganesan 505388 R 65 M 2 1 6/60 12.2 14 6/15 6/12 6/12 6/12 6/12 12.2 12.2 14.4 14.4 14.4 Iris Bleeding 
17 Raju 465225 R 65 M 1 6/12 2/60 10.2 12 6/12 6/12 6/9 6/9 6/9 12.2 12.2 12.2 12.2 12.2 Laser Markings over IOL 
18 Kalyani 497020 L 45 F 1 10/12 4/60 10.2 12 6/60 6/60 6/36 6/24 6/24 14.4 10.2 10.2 10.2 10.2  
19 Periyaponnu 447007 R 65 F 2 2 6/60 10.2 50 6/18 6/18 6/18 6/18 6/12 10.2 10.2 10.2 10.2 10.2 IOL markings 
 
20 Arivazhagan 469157 L 75 M 1 1
1/2
 6/60 14.6 39 6/36 6/24 6/6 6/6 6/6 30.2 10.2 14.6 14.6 14.6 Increased IOP 
21 Valliammal 486495 R 55 F 1 2 6/60 12.2 11 6/18 6/18 6/18 6/12 6/12 14.8 14.8 12.2 12.2 12.2 Laser Markings over IOL 
22 Thangasamy 416482 L 54 M 1 1 6/60 14.6 11 6/12 6/12 6/12 6/12 6/12 14.6 10.2 14.6 14.6 14.6  
23 Chandran 506165 L 56 M 1 1
1/2
 3/60 12.2 11 6/36 6/24 6/12 6/12 6/12 14.6 12.2 14.6 12.2 12.2  
24 Sivaraman 456052 R 58 M 1 8/12 5/60 17.3 132 5/60 5/60 5/60 5/60 5/60 12.2 12.2 14.4 14.4 14.4  
25 Saminathan 475920 L 56 M 1 2 4/60 12.2 112 6/36 6/24 6/12 6/12 6/12 14.6 14.6 12.2 12.2 12.2  
26 Jothiammal 455793 R 65 M 1 1
1/2
 6/36 12.2 54 6/24 6/24 6/18 6/18 6/18 14.6 14.6 12.2 12.2 12.2 Laser Markings over IOL 
27 Perumal Akka 484025 L 70 F 1 3 5/60 12.2 148 6/36 6/36 6/24 6/24 6/24 14.4 12.2 12.2 12.2 12.2  
28 Mohammed Ibrahim 422488 L 62 M 1 4 5/60 14.6 16 6/18 6/12 6/12 6/12 6/9 14.6 14.6 14.6 14.6 14.6  
29 Janaki 492489 L 40 F 1 3 3/60 17.3 46 6/60 6/60 6/36 6/36 6/36 17.3 17.3 17.3 17.3 17.3  
30 Subathra 466244 L 35 F 1 1 4/60 17.3 128 6/36 6/36 6/36 6/24 6/24 14.8 14.8 17.3 17.3 17.3  
31 Perumayee 450640 L 78 F 1 1
1/4
 6/60 17.3 25 6/36 6/36 6/24 6/18 6/18 17.3 17.3 14.6 14.6 14.6 Laser Markings over IOL 
32 Pavithra 509156 R 16 F 1 1 6/36 17.3 140 6/24 6/18 6/12 6/12 6/12 17.3 17.3 17.3 17.3 17.3  
33 Mariammal 486187 L 70 F 2 1 5/60 10.2 102 6/60 6/36 6/36 6/36 6/18 14.6 14.6 10.2 10.2 10.2  
34 Rajamani 443472 R 68 F 1 2 6/24 12.2 40 6/12 6/12 6/6 6/6 6/6 12.2 12.2 12.2 12.2 12.2  
35 Thambiraja 392313 L 78 M 2 1
1/2
 6/60 12.2 30 6/18 6/18 6/12 6/9 6/9 14.6 14.6 12.2 12.2 12.2 Iris Bleeding 
36 Rasu thevar 456249 L 65 M 1 1 6/36 17.3 10 6/12 6/18 6/18 6/9 6/9 17.3 17.3 14.8 17.3 17.3 Laser Markings over IOL 
37 Gayathri 413151 R 11 F 2 1 3/60 12.2 75 6/60 6/36 6/36 6/36 6/36 14.8 12.2 12.2 12.2 12.2  
38 Karuppaye 435001 R 65 F 1 2 6/60 12.3 29 6/12 6/12 6/12 6/9 6/9 14.6 12.2 12.2 12.2 12.2  
39 Suja 491408 L 17 F 1 6/12 6/60 12.2 75 6/12 6/12 6/6 6/6 6/6 14.4 12.2 12.2 12.2 12.2 Laser Markings over IOL 
40 Aishwarya  460027 L 20 F 1 4 6/60 10.2 75 CFCF CFCF CFCF CFCF CFCF 12.2 10.2 10.2 10.2 10.2  
41 Thendral 479257 L 37 F 1 3 3/60 17.3 49 6/12 6/9 6/9 6/9 6/9 17.3 14.6 14.6 17.3 17.3 Laser Markings over IOL 
42 Rajamani 429241 R 65 F 1 2 5/60 14.6 56 6/36 6/36 6/36 6/12 6/12 17.3 17.3 14.6 14.6 14.6 Iris Bleeding 
43 Meena 430106 L 13 F 1 1
1/2
 1/60 17.3 220 1/60 1/60 1/60 1/60 1/60 17.3 17.3 17.3 17.3 17.3  
44 Manickam 500084 R 75 M 1 1 6/24 17.3 95 6/12 6/6 6/6 6/6 6/6 17.3 17.3 17.3 17.3 17.3  
45 Thulasi 470247 L 66 M 1 1 
1/2
/60 14.6 53 
1/2
/60 
1/2
/60 
1/2
/60 
1/2
/60 
1/2
/60 14.6 14.6 14.6 14.6 14.6  
46 Arokiamary 469943 L 73 F 1 6/12 3/60 14.6 81 6/60 6/60 6/18 6/12 6/12 20.3 17.3 14.6 14.6 14.6  
47 Mymoon beevi 398712 R 65 F 1 8/12 6/36 17.3 46 6/24 6/18 6/18 6/18 6/18 17.3 17.3 14.6 14.6 14.6 IOL Markings 
 
 
 
48 Kumaran 450487 R 50 M 1 6/12 5/60 14.4 54 6/36 6/18 6/18 6/18 6/18 20.3 20.3 14.4 14.4 14.4  
49 Ramamoorthy 410325 L 50 F 1 1
1/2
 3/60 17.3 60 6/12 6/12 6/12 6/12 6/9 17.3 17.3 17.3 17.3 17.3 Laser Markings over IOL 
50 Arumugam 476387 R 60 M 1 1
1/4
 6/60 12.2 43 6/18 6/18 6/18 6/12 6/12 17.3 17.3 12.2 12.2 12.2  
51 Thotichi Ammal 506793 L 49 F 1 2 3/60 14.6 75 6/24 6/18 6/12 6/12 6/12 17.3 14.6 14.6 14.6 14.6  
52 Ochammal 388342 L 60 F 1 2
1/2
 3/60 14.3 175 6/36 6/36 6/24 6/24 6/24 14.6 14.6 12.2 12.2 14.6  
53 Annamalai 439834 L 60 M 1 1 1/60 12.2 30 1/60 1/60 1/60 1/60 1/60 17.3 17.3 12.2 12.2 12.2  
54 Jaya 499830 R 50 F 1 1 3/60 17.3 66 6/18 6/18 6/12 6/12 6/12 20.8 17.3 17.3 17.3 17.3  
55 Veerammal 470302 L 75 F 1 8/12 3/60 14.6 75 6/60 6/60 6/36 6/36 6/36 17.3 14.6 14.6 14.6 14.6 Laser Markings over IOL 
56 Shankaramal 410366 R 55 F 1 10/12 6/60 14.6 40 6/18 6/18 6/18 6/12 6/12 14.6 14.6 14.6 14.6 14.6  
57 Lakshmanan 480380 R 80 M 1 9/12 5/60 10.2 49 6/36 6/24 6/18 6/18 6/18 14.6 10.2 10.2 10.2 10.2  
58 Thangasami 395688 L 60 M 1 10/12 6/60 17.3 102 6/36 6/24 6/18 6/12 6/12 17.3 17.3 14.6 14.6 14.6  
59 Krishnan 474685 R 50 M 1 1 2/60 17.3 34 6/18 6/18 6/18 6/18 6/12 17.3 17.3 17.3 17.3 17.3 IOL 
60 Ponnuthai 487236 L 75 F 1 1
1/2
 6/60 12.2 38 6/18 6/12 6/12 6/12 6/12 14.6 14.6 12.2 12.2 12.2  
61 Vijaya 372697 R 45 F 1 1
1/4
 6/36 14.6 48 6/12 6/9 6/9 6/6 6/6 14.6 14.6 14.6 14.6 14.6 Laser Markings over IOL 
62 Geetha 486982 R 45 F 1 1
1/2
 3/60 17.3 102 6/24 6/24 6/12 6/12 6/12 17.6 17.3 14.6 14.6 14.6  
63 Anwardeen 449827 L 60 M 1 2 3/60 12.2 10 6/36 6/9 6/9 6/9 6/6 17.3 17.3 12.2 12.2 12.2  
64 Santhanamal 482649 L 57 F 2 8/12 4/60 12.2 79 6/24 6/18 6/12 6/9 6/9 12.2 12.2 12.2 12.2 12.2 Vitreous in AC 
65 Dharmar 457990 L 70 M 1 1 3/60 17.3 48 6/18 6/12 6/12 6/9 6/9 20.3 17.3 17.3 17.3 17.3  
66 Veersinnu 502671 R 50 F 1 1 4/60 12.2 69 6/18 6/12 6/12 6/12 6/9 14.6 12.6 12.6 12.2 12.2  
67 Maharaja 482609 R 70 M 1 1
1/2
 5/60 17.3 58 6/12 6/9 6/9 6/9 6/9 17.3 17.3 14.6 14.6 14.6  
68 Gopal 507381 L 60 M 1 2 6/60 17.3 39 6/12 6/12 6/9 6/9 6/9 17.3 17.3 17.3 17.3 17.3  
69 Ayyathurai 475651 L 70 M 1 1 6/60 14.6 30 6/18 6/12 6/12 6/12 6/12 17.3 17.3 14.6 14.6 14.6  
70 Pangajam 449858 R 60 F 1 1
1/2
 6/36 14.6 98 6/9 6/9 6/9 6/9 6/9 20.3 17.6 14.6 14.6 14.6 Iris Bleeding 
71 Chandra 477652 R 45 F 1 1
1/4
 2/60 14.6 79 6/24 6/24 6/18 6/18 6/18 17.3 14.6 14.6 14.6 14.6 Laser Markings over IOL 
72 Kasiviswanathan 500611 L 39 M 1 1 6/24 17.3 37 6/9 6/9 6/6 6/6 6/6 17.3 14.6 14.6 14.6 14.6  
73 Saminathan 469242 L 58 M 1 2 6/60 17.3 75 6/12 6/9 6/9 6/9 6/9 17.3 17.3 14.6 14.6 14.6  
74 Annakodi 409257 L 50 F 1 10/12 6/36 12.2 45 6/9 6/6 6/6 6/6 6/6 14.6 12.8 12.8 12.8 12.8  
75 Ganga devi 379056 R 55 F 1 11/12 5/60 14.6 19 6/18 6/12 6/12 6/12 6/12 17.3 17.3 14.6 14.6 14.6 Laser Markings over IOL 
 
 
 
76 Pandithurai 435686 R 65 M 1 1 5/60 20.3 11 6/18 6/18 6/18 6/12 6/12 20.3 17.3 17.3 17.3 17.3  
77 Saroja 465982 L 60 F 1 1
1/2
 5/60 12.2 72 6/9 6/9 6/6 6/6 6/6 14.6 12.2 12.2 12.2 12.2  
78 Ramuthai 472784 R 57 F 1 1 6/60 17.3 12 6/12 6/9 6/9 6/9 6/9 20.3 17.3 17.3 17.3 17.3  
79 Karupasamy 389128 L 60 M 1 1
1/4
 6/60 14.6 21 6/12 6/12 6/12 6/12 6/12 14.6 14.6 14.6 12.8 12.8  
80 Veerasamy 482890 L 55 M 2 2 6/60 17.3 46 6/12 6/9 6/9 6/9 6/9 20.3 20.3 20.3 20.3 20.3 Vitreous in AC 
81 Paramaraj 499152 L 75 M 1 6/12 6/60 14.6 40 6/36 6/24 6/6 6/6 6/6 10.2 10.2 14.6 14.6 14.6  
82 Seeni thevar 457010 R 65 M 1 1 6/60 10.2 50 6/18 6/18 6/18 6/12 6/12 10.2 10.2 10.2 10.2 10.2  
83 Muthuraj 487027 L 45 M 1 1
1/2
 2/60 10.2 12 6/60 6/60 6/36 6/24 6/24 14.4 10.2 10.2 10.2 10.2 Laser Markings over IOL 
84 Pappu 425272 R 65 M 1 8/12 
4
/60 12.2 12 6/12 6/12 6/9 6/9 6/9 12.2 12.2 12.2 12.2 12.2  
85 Karuppi 505488 R 65 F 1 10/12 6/10 14.4 36 6/18 6/12 6/12 6/12 6/12 17.3 14.4 14.4 14.4 14.4  
86 Vasu 479072 L 55 M 1 9/12 6/60 17.3 40 6/18 6/12 6/12 6/12 6/12 17.3 17.3 17.3 17.3 17.3 Laser marketing over IOL 
87 Banumathi 44567 L 45 F 1 10/12 3/60 17.3 48 6/36 6/36 6/12 6/6 6/6 17.3 17.3 17.3 17.3 17.3  
88 Palraj 458068 R 70 M 1 1 4/60 12.2 18 6/60 6/60 6/36 6/36 6/18 10.2 10.2 12.2 12.2 12.2  
89 Sundaram 377919 R 40 M 1 1 6/36 12.2 54 6/18 6/18 6/12 6/12 6/12 14.6 12.2 12.2 12.2 12.2  
90 Petchi 482098 L 55 F 2 8/12 6/60 17.3 40 6/36 6/18 6/18 6/18 6/18 20.3 17.3 17.3 17.3 17.3 Vitreous in AC 
91 Gopalakrishnan 481240 L 65 M 1 1
1/2
 5/60 17.3 96 6/12 6/9 6/9 6/9 6/9 17.3 17.3 17.3 17.3 17.3  
92 Kamatchi 489098 R 73 M 1 1
1/4
 6/60 14.6 46 6/24 6/24 6/18 6/12 6/12 14.6 14.6 14.6 14.6 14.6 Laser Markings over IOL 
93 Balan 508679 L 60 M 1 1 3/60 12.8 49 6/60 6/60 6/36 6/36 6/36 14.6 14.6 12.8 12.8 12.8 Flare and Cells in AC 
94 Narayanan 489018 R 70 M 1 1 4/60 14.6 46 6/24 6/24 6/12 6/12 6/12 14.6 14.6 14.6 14.6 14.6  
95 Deivam 471230 L 65 M 1 8/12 5/60 17.3 48 6/18 6/18 6/12 6/12 6/12 20.3 17.3 17.3 17.3 17.3  
96 Chellathai 497814 R 60 F 1 10/12 4/60 15.6 50 6/18 6/12 6/12 6/12 6/12 15.6 15.6 15.6 15.6 15.6  
97 Kanmani 468768 L 55 F 1 1
1/2
 6/60 14.4 30 6/12 6/9 6/9 6/9 6/9 14.4 14.4 14.4 14.4 14.4 IOL markings 
98 Chittupillai 496889 L 70 F 1 2 2/60 10.2 56 6/36 6/36 6/24 6/24 6/24 14.4 10.2 10.2 10.2 10.2  
99 Devaki 489848 R 60 F 2 1
1/2
 3/60 17.3 36 6/18 6/18 6/18 6/18 6/18 17.3 17.3 17.3 17.3 17.3  
100 Mayandi 443476 R 68 M 1 2
1/2
 6/60 12.2 26 6/12 6/12 6/9 6/9 6/9 14.4 12.2 12.2 12.2 12.2 IOL markings 
 
 
 
*Type of surgery   :  1   - Pl.  ECCE with IOL  2 – Pl. ECCE 
